KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Revenue (2017 - 2025)

Twist Bioscience (TWST) has disclosed Revenue for 6 consecutive years, with -$1000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Revenue fell 100.0% to -$1000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $178.2 million, a 12.48% decrease, with the full-year FY2024 number at -$29000.0, down 480.0% from a year prior.
  • Revenue was -$1000.0 for Q3 2023 at Twist Bioscience, down from $63.7 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $63.7 million in Q2 2023 to a low of -$1000.0 in Q3 2023.
  • A 5-year average of $34.1 million and a median of $32.4 million in 2020 define the central range for Revenue.
  • Peak YoY movement for Revenue: surged 106.09% in 2020, then tumbled 100.0% in 2023.
  • Twist Bioscience's Revenue stood at $17.2 million in 2019, then soared by 64.07% to $28.2 million in 2020, then skyrocketed by 49.21% to $42.0 million in 2021, then increased by 29.09% to $54.2 million in 2022, then crashed by 100.0% to -$1000.0 in 2023.
  • Per Business Quant, the three most recent readings for TWST's Revenue are -$1000.0 (Q3 2023), $63.7 million (Q2 2023), and $60.2 million (Q1 2023).